We are seeking pilot projects and strategic partners!
KiwiTech, LLC, an innovation platform that helps startups build viable products, drive traction, and raise capital, today announced a strategic partnership with Jeeva Informatics Solutions Inc, an AI-driven startup that builds patient-focused big data and digital health solutions for accelerating clinical research.
The Center for Innovative Technology (CIT) today announced that CIT GAP Funds has invested in Herndon, Va.-based Jeeva Informatics Solutions Inc. (Jeeva), a precision medicine data science company focused on significantly accelerating clinical trial operations by taking trials to patients’ homes. Using AI and digital health technologies, Jeeva fast tracks patient recruitment, improves adherence to trial protocols, and reduces patient burden and dropout rates, solving some of the pressing challenges in bringing innovative medicines to market effectively. Jeeva plans to use the GAP Funds investment to advance customer pilot projects and use cases for further validation.
"No one knows the long term implications of cell and gene therapies because they are a one and done type treatment. If a patient receives therapy today, they are done, and so the FDA has mandated that recipients need to be monitored for up to 15 years. We are looking to address this issue with digital health technologies and AI,” says Harsha Rajasimha, Founder and CEO of Jeeva.
By any measure, Harsha Rajasimha, PhD, was a successful man. He had published journal articles and chapters in professional textbooks; he had received patents, honors, and awards for his work. But none of these accomplishments equipped him to help his baby, who died from Edwards Syndrome, a rare congenital disease.
"AI and Bigdata strategies in accelerating clinical research for faster rare disease cures." - Keynote presentation by our Founder & CEO, Dr. Harsha Rajasimha at the BioIT World West Conference. Harsha will also be a panelist to share multi-stakeholder perspectives.
Jeeva Informatics joins Global Genes Corporate Alliance and VABIO to accelerate rare disease clinical research for patient groups, academic clinical investigators, and biopharmaceutical sponsors,.
A team of four from Virginia based Jeeva Informatics solutions completed the National Science Foundation (NSF) innovation corps (I-Corps) program - a nationally competitive and intense 7-week program. The team interviewed over 100 customer stakeholders from biotech sponsors, patient advocacy groups, research organizations, academic researchers, key opinion leaders, and regulators.